ICD-10 Coding for Metastatic Melanoma(C22.0D, C78.7, C78.7B)
Comprehensive guide to ICD-10 coding for metastatic melanoma, including primary and secondary site codes, documentation requirements, and common pitfalls.
Complete code families applicable to Metastatic Melanoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C79.5 | Secondary malignant neoplasm of bone | Use when melanoma has metastasized to bone, confirmed by imaging or biopsy. |
|
| C78.7 | Secondary malignant neoplasm of liver and intrahepatic bile duct | Use when melanoma has metastasized to the liver, confirmed by imaging or biopsy. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutMetastatic Melanoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Metastatic Melanoma.
Omitting primary melanoma status
Impact
Clinical: Impacts treatment decisions, Regulatory: Non-compliance with coding standards, Financial: Potential claim denials
Mitigation
Always document primary status, Use history codes if primary is excised
Coding primary melanoma when only metastasis is present
Impact
Reimbursement: Incorrect coding can lead to claim denials., Compliance: Non-compliance with ICD-10 guidelines., Data Quality: Inaccurate patient records and statistics.
Mitigation
Use secondary codes (C79._) for metastasis and Z85.820 if primary is excised.
Metastasis coding
Impact
Incorrect sequencing of primary and secondary codes.
Mitigation
Train staff on proper sequencing rules.